Physician
Ronald N Skufca DO PA
Ronald N Skufca DO PA was paid $9.62M by Medicaid between Jan 2018 and Dec 2024, across 153 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoRONALD N SKUFCA DO PA
DALLAS, TX 75206
DALLAS, TX 75206
33aNPI1558433250assigned 11/15/2006
33bProvider typeFamily Medicine Physician
28Total paid$9.62M
24GClaims416,617
24DCodes billed153
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#7 of 1,204
Median peer was paid$31K
This provider vs. median312×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,578 | $18K | |
| 2019 | 1,810 | $18K | |
| 2020 | 37,657 | $663K | |
| 2021 | 95,270 | $1.92M | |
| 2022 | 104,323 | $2.74M | |
| 2023 | 89,448 | $2.18M | |
| 2024incomplete | 86,531 | $2.08M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 68,224 | 62,809 | $2.37M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 16% | 19,356 | 18,954 | $1.52M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 10% | 20,155 | 19,628 | $1.00M |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.9% | 19,416 | 19,053 | $565K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.0% | 5,952 | 5,909 | $485K |
| 87634 | 5.0% | 8,332 | 8,188 | $484K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.0% | 5,529 | 5,413 | $480K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.5% | 8,968 | 8,474 | $437K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.6% | 14,591 | 14,073 | $348K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.6% | 4,459 | 4,408 | $346K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 30,003 | 28,666 | $182K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.6% | 2,048 | 1,989 | $154K |
141 more codes
| 99000 | 1.5% | 14,513 | $147K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.4% | 12,832 | $137K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.3% | 13,741 | $122K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,459 | $75K |
| 99050 | <1% | 5,024 | $74K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,309 | $74K |
| 80053 | Comprehensive metabolic panel | <1% | 8,674 | $63K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 784 | $61K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,383 | $46K |
| 80061 | Lipid panel | <1% | 4,499 | $44K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,811 | $44K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,153 | $42K |
| 80050 | General health panel | <1% | 897 | $27K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,181 | $26K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,789 | $24K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,686 | $22K |
| 81003 | <1% | 11,178 | $19K | |
| 92567 | <1% | 1,288 | $15K | |
| 82947 | <1% | 6,943 | $13K | |
| 82044 | <1% | 3,310 | $13K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 1,000 | $12K |
| 90473 | <1% | 1,124 | $12K | |
| 96160 | <1% | 5,431 | $10K | |
| 93000 | <1% | 952 | $9K | |
| 94060 | <1% | 251 | $9K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 202 | $8K |
| 83655 | <1% | 812 | $8K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,647 | $8K |
| 99091 | <1% | 44 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 578 | $6K |
| 87807 | <1% | 535 | $6K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 101 | $6K |
| 83013 | <1% | 73 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,853 | $4K |
| 90686 | <1% | 5,353 | $3K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 349 | $3K |
| 74019 | <1% | 96 | $3K | |
| 0012A | <1% | 91 | $3K | |
| 0011A | <1% | 90 | $3K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 38 | $3K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 47 | $3K |
| 90674 | <1% | 118 | $2K | |
| 84481 | <1% | 173 | $2K | |
| 84439 | <1% | 315 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 28 | $2K |
| 86703 | <1% | 172 | $2K | |
| 99460 | <1% | 24 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 15 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 267 | $2K |
| 90688 | <1% | 115 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,012 | $1K |
| 90656 | <1% | 887 | $1K | |
| 99490 | Ccm add 20min | <1% | 1,311 | $1K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $983.19 |
| 90670 | <1% | 1,667 | $936.28 | |
| 99462 | <1% | 24 | $874.92 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 32 | $683.63 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 32 | $683.63 |
| 81025 | <1% | 76 | $535.39 | |
| 92250 | <1% | 15 | $527.68 | |
| 3044F | <1% | 2,254 | $480.00 | |
| 83014 | <1% | 73 | $437.90 | |
| 84153 | <1% | 26 | $425.37 | |
| 82728 | <1% | 37 | $423.65 | |
| 0013A | <1% | 27 | $363.20 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 15 | $314.89 |
| 99429 | <1% | 12 | $283.54 | |
| 90651 | <1% | 1,403 | $272.56 | |
| 94760 | <1% | 148 | $262.60 | |
| 3046F | <1% | 787 | $220.00 | |
| 90715 | <1% | 552 | $219.51 | |
| 92285 | <1% | 15 | $162.49 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 14 | $157.42 |
| 90734 | <1% | 1,706 | $155.35 | |
| 99439 | <1% | 302 | $142.08 | |
| 3051F | <1% | 200 | $140.00 | |
| 87481 | <1% | 14 | $127.94 | |
| 86308 | <1% | 28 | $121.80 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 2,679 | $117.28 |
| 82274 | <1% | 12 | $98.13 | |
| 86580 | <1% | 14 | $90.44 | |
| 84479 | <1% | 170 | $70.85 | |
| 84436 | <1% | 172 | $57.96 | |
| 84550 | <1% | 16 | $53.52 | |
| 82950 | <1% | 12 | $47.88 | |
| 99487 | Ccm add 20min | <1% | 82 | $44.90 |
| 88142 | <1% | 213 | $34.04 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,163 | $5.25 |
| 90677 | <1% | 569 | $3.25 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $2.06 |
| 90680 | <1% | 1,136 | $0.10 | |
| 90723 | <1% | 502 | $0.09 | |
| 90648 | <1% | 956 | $0.08 | |
| 90633 | <1% | 1,408 | $0.03 | |
| 90707 | <1% | 282 | $0.02 | |
| 90716 | <1% | 293 | $0.02 | |
| 3354F | <1% | 16 | $0.02 | |
| 3353F | <1% | 61 | $0.02 | |
| 99177 | <1% | 1,081 | $0.01 | |
| 90713 | <1% | 12 | $0.01 | |
| 3079F | <1% | 3,669 | $0.01 | |
| 3078F | 0% | 4,592 | $0.00 | |
| 1159F | 0% | 11,157 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 1,443 | $0.00 |
| 1160F | 0% | 11,158 | $0.00 | |
| 90700 | 0% | 340 | $0.00 | |
| 3077F | 0% | 746 | $0.00 | |
| 0502F | 0% | 1,575 | $0.00 | |
| 2028F | 0% | 304 | $0.00 | |
| 90710 | 0% | 413 | $0.00 | |
| 1090F | 0% | 49 | $0.00 | |
| 3050F | 0% | 92 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 482 | $0.00 |
| 3288F | 0% | 55 | $0.00 | |
| G8476 | Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg | 0% | 39 | $0.00 |
| 99497 | 0% | 18 | $0.00 | |
| 1125F | 0% | 3,500 | $0.00 | |
| 1034F | 0% | 433 | $0.00 | |
| 1126F | 0% | 1,132 | $0.00 | |
| 3008F | 0% | 6,121 | $0.00 | |
| 3074F | 0% | 6,332 | $0.00 | |
| 3060F | 0% | 910 | $0.00 | |
| 3075F | 0% | 1,071 | $0.00 | |
| 90620 | 0% | 130 | $0.00 | |
| 1000F | 0% | 429 | $0.00 | |
| 90697 | 0% | 278 | $0.00 | |
| 1036F | 0% | 52 | $0.00 | |
| 90698 | 0% | 72 | $0.00 | |
| 1220F | 0% | 946 | $0.00 | |
| 90696 | 0% | 400 | $0.00 | |
| 91301 | 0% | 174 | $0.00 | |
| 3049F | 0% | 41 | $0.00 | |
| 0501F | 0% | 171 | $0.00 | |
| 3048F | 0% | 221 | $0.00 | |
| 0503F | 0% | 59 | $0.00 | |
| 3080F | 0% | 214 | $0.00 | |
| 3061F | 0% | 747 | $0.00 | |
| 3351F | 0% | 26 | $0.00 | |
| 1170F | 0% | 54 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 34 | $0.00 |
| 99459 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSKUFCA, RONALD (MEDICAL DIRECTOR)
Parent organizationRONALD N SKUFCA, DO PA